RT Journal Article
SR Electronic
T1 A Look into the Future: Elinogrel, Cangrelor, PAR Antagonists, and Aptamers
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 3
SP 33
OP 33
DO 10.1177/155989771103021
UL http://mdc.sagepub.com/content/11/3/33.abstract
AB There are several antiplatelet agents with diverse mechanisms of action that are or will be available for treatment of the growing population of patients with cardiovascular disease. The challenge will be to understand which patients may benefit from these therapies in combination with current treatment regimens and in the context of increasingly complex patients (eg, the elderly and diabetics).